Journal
AGE
Volume 38, Issue 4, Pages 303-322Publisher
SPRINGER
DOI: 10.1007/s11357-016-9929-7
Keywords
Aged; Alzheimer's disease; APP/PS1 mice; beta-amyloid; Hippocampal atrophy; Noncognitive abnormalities
Categories
Funding
- National Natural Science Foundation of China [30971020, 30973517]
- Natural Science Foundation of Jiangsu Educational Department [09KJA310003]
Ask authors/readers for more resources
Transgenic APPSwe/PS1dE9 (APP/PS1) mice that overproduce amyloid beta (A beta) are extensively used in the studies of pathogenesis and experimental therapeutics and new drug screening for Alzheimer's disease (AD). However, most of the current literature uses young or adult APP/PS1 mice. In order to provide a broader view of AD-like phenotype of this animal model, in this study, we systematically analyzed behavioral and pathological profiles of 24-month-old male APP/PS1 mice. Aged APP/PS1 mice had reference memory deficits as well as anxiety, hyperactivity, and social interaction impairment. Consistently, there was obvious deposition of amyloid plaques in the dorsal hippocampus with decreased expression of insulin-degrading enzyme, a proteolytic enzyme responsible for degradation of intracellular A beta. Furthermore, decreases in hippocampal volume, neuronal number and synaptophysin expression, and astrocyte atrophy were also observed in aged APP/PS1 mice. This finding suggests that aged APP/PS1 mice can well replicate cognitive and noncognitive behavioral abnormalities, hippocampal atrophy, and neuronal and astrocyte degeneration in AD patients, to enable more objective and refined preclinical evaluation of therapeutic drugs and strategies for AD treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available